UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~PURSUANT~~Date TOof ~~SECTION~~Report ~~13 OR 15~~(d)Date ~~OF THE~~of ~~SECURITIES~~earliest ~~EXCHANGE~~event ~~ACT~~reported): OFNovember ~~1934~~4, 2010

~~Date of Report: October 13~~Osteotech, ~~2010~~Inc. (~~Date~~Exact name of ~~earliest~~registrant ~~event~~as ~~reported~~specified in its charter)

Osteotech, Inc.


Delaware	000-34612	13-3357370
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

(Exact name of registrant as specified in its charter)


51 James Way, Eatontown, New Jersey		07724
(Address of Principal Executive Offices)		(Zip Code)

~~Commission~~Registrant’s ~~File~~telephone ~~Number~~number, including area code: ~~001~~(732) 542-~~34612~~2800

~~Delaware~~Not Applicable (~~State~~Former name or ~~other~~former ~~jurisdiction~~address ofif ~~incorporation)~~changed ~~13-3357370~~since ~~(IRS~~last ~~Employer Identification No~~report.)

51 James Way Eatontown, New Jersey 07724 (Address of principal executive offices, including zip code)

(732) 542-2800 (Registrant’s telephone number, including area code)

Not Applicable (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

oItem ~~Pre-commencement communications pursuant to Rule 14d-~~2~~(b)~~.02 ~~under~~Results ~~the~~of ~~Exchange~~Operations ~~Act~~and ~~(17~~Financial ~~CFR 240~~Condition.~~14d-2(b))~~

oOn ~~Pre-commencement~~November 4, ~~communications~~2010, ~~pursuant~~Osteotech, toInc. ~~Rule~~issued ~~13e-4(c)~~a ~~under~~press release announcing its financial results for the ~~Exchange~~quarter ~~Act~~ended September 30, ~~(17~~2010. ~~CFR~~A ~~240~~copy of the press release is attached hereto as Exhibit 99.~~13e-4(c))~~1, which is incorporated herein by reference.

The information furnished pursuant to Item 2.02 8of this Current Report and in Exhibit 99.011 hereto shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. ~~Other~~The ~~Events~~information in this Item 2.02 and in Exhibit 99.1 hereto shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

OnItem ~~October 13, 2010, Osteotech, Inc~~9.01 ~~announced~~Financial ~~that~~Statements ~~it had received notification that the U.S. Department of Justice~~ and ~~Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period for its proposed merger with Medtronic, Inc~~Exhibits. A copy of the press release issued by Osteotech, Inc. announcing the early termination of the Hart-Scott-Rodino waiting period is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

~~Item 9.01 Financial Statements and~~ (d) Exhibits.

~~(d) Exhibits~~99.1 Press Release of Osteotech, Inc., dated November 4, 2010.

~~SIGNATURE~~SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

OSTEOTECH, INC. By: /s/ Mark H. Burroughs Mark H. Burroughs Executive Vice President, ~~and~~ Chief Financial Officer

Date: ~~October~~November 134, 2010

Exhibit
Number		Description
	99.1	Press Release of Osteotech, Inc., dated October 13, 2010, announcing early termination of the Hart-Scott-Rodino waiting period.

EXHIBIT INDEX


Exhibit
Number		Description
99. 1		Press Release of Osteotech, Inc., dated November 4, 2010.

Filing Compare · OSTEOTECH INC